Concord Drugs fundamental analysis
CONCORD
77.18
3.67 (4.99%)Last updated on 10 Dec, 2025 | 14:37 IST
BUYSELL
The current prices are delayed, login to your account for live prices
Login Concord Drugs Fundamentals
P/E Ratio
168.14
P/B Ratio
2.11
Div. Yield
0
Sector P/E
36.18
Sector P/B
1.15
Sec. Div. Yield
0.57
Concord Drugs Fundamentals is currently trading with a P/E Ratio of 168.14, compared to the sector average of 36.18. Its P/B Ratio stands at 2.11, while the sector’s is 1.15. In terms of returns, the stock offers a Dividend Yield of 0%, which is than the sector’s 0.57%.
Concord Drugs Score Card
Price
Attractive
Growth
Poor
Quality
Poor
Management
Poor
On its scorecard, Concord Drugs reflects: Price – Attractive, Growth – Poor, Quality – Poor, and Management – Poor. Together, these indicators provide a structured view of the company’s fundamentals.
